• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

NanoEcho

0.04 SEK+3.89 %16/7 17:29
Less than 1K followers

NANECH

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+3.89 %
-11.37 %
+55.83 %
-46.73 %
-50.65 %
-61.12 %
-
-
-75.06 %

NanoEcho operates in the healthcare sector, with a primary focus on rectal cancer diagnostics. The company is currently in the clinical stage, developing a new diagnostic method to determine whether early rectal cancer has spread to nearby lymph nodes. The method aims to provide an accurate diagnosis and personalized treatment. NanoEcho was founded in 2013 and is headquartered in Lund.

Read more
Market cap
17.59M SEK
Turnover
14.85K SEK
Revenue
488K
EBIT %
-3,030.53 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
25/8
2026

Interim report Q2'26

27/10
2026

Interim report Q3'26

All
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue K

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Press release2026-06-25 11:30

NanoEcho presenterade vid en internationell workshop om magnetomotoriskt ultraljud

NanoEcho
Regulatory press release2026-06-17 20:35

NanoEcho offentliggör utfall för nyttjande av teckningsoptioner av serie TO2

NanoEcho
Regulatory press release2026-06-17 11:05

NanoEcho rapporterar resultat från den inledande kliniska delen av Proof of Concept-studien

NanoEcho

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release2026-06-12 11:10

NanoEcho utser ny Chief Financial Officer

NanoEcho
Regulatory press release2026-06-01 14:50

Teckningskursen för utnyttjande av teckningsoptioner av serie TO2 i NanoEcho har fastställts till 0,05 SEK per aktie inför utnyttjandeperioden som inleds idag den 1 juni 2026

NanoEcho
Regulatory press release2026-05-28 11:15

Årsstämma i NanoEcho AB (publ) den 28 maj 2026

NanoEcho
Regulatory press release2026-05-27 19:00

Valberedningens förslag i NanoEcho AB (publ) inför årsstämman 2026

NanoEcho
Press release2026-05-22 13:30

NanoEcho utser Nils Löfgren till CTO

NanoEcho
Press release2026-05-20 10:00

NanoEchos forskningssystem vid Lunds universitet är klart för användning

NanoEcho
Press release2026-05-06 13:00

NanoEcho startar analysfasen av den inledande delen av Proof of Concept-studien

NanoEcho
Regulatory press release2026-04-30 08:30

NanoEcho AB (publ): Kvartalsrapport Q1 2026

NanoEcho
Press release2026-04-29 16:00

NanoEcho levererar magnetomotoriskt ultraljudssystem till Lunds universitet

NanoEcho
Regulatory press release2026-04-27 15:10

KALLELSE TILL ÅRSSTÄMMA I NANOECHO AB (PUBL)

NanoEcho
Press release2026-04-27 13:00

Samtliga friska studiedeltagare har genomfört den inledande Proof of Concept-studien och analysfasen förbereds

NanoEcho
Press release2026-04-22 13:45

NanoEcho får designrelaterat patent godkänt i USA

NanoEcho
Press release2026-04-17 13:00

NanoEcho slutför mjukvaruanpassningar och systemtester inför leverans av forskningssystem till Lunds universitet

NanoEcho
Regulatory press release2026-03-26 12:10

Rättelse: NanoEcho registrerar ytterligare units tecknade i företrädesemissionen och beslutar om en riktad emission av units till emissionsgaranten

NanoEcho
Regulatory press release2026-03-26 10:00

NanoEcho registrerar ytterligare units tecknade i företrädesemissionen och beslutar om en riktad emission av units till emissionsgaranten

NanoEcho
Regulatory press release2026-03-26 08:30

NanoEcho publicerar årsredovisning för 2025

NanoEcho
Regulatory press release2026-03-20 18:15

NanoEcho delregistrerar emissionslikvid efter företrädesemission

NanoEcho